INmune Bio (INMB) Insider Trading & Ownership $4.88 +0.08 (+1.67%) (As of 05:19 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends INmune Bio (NASDAQ:INMB) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage35.20%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$236,436.60Number OfInsiders Selling(Last 12 Months)0 Get INMB Insider Trade Alerts Want to know when executives and insiders are buying or selling INmune Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address INMB Insider Buying and Selling by Quarter Ad Weiss Ratings“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.Learn these 4 simple steps and protect your savings before it’s too late. INmune Bio Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/30/2024David J MossCFOBuy10,000$5.29$52,900.00 9/12/2024David J MossCFOBuy7,690$6.38$49,062.20 9/12/2024Raymond Joseph TesiCEOBuy15,380$6.38$98,124.40 6/25/2024Scott JudaDirectorBuy5,000$7.27$36,350.00 (Data available from 1/1/2013 forward) INMB Insider Trading Activity - Frequently Asked Questions Who is on INmune Bio's Insider Roster? The list of insiders at INmune Bio includes David J Moss, Raymond Joseph Tesi, Scott Juda, and Timothy J Schroeder. Learn more on insiders at INMB. What percentage of INmune Bio stock is owned by insiders? 35.20% of INmune Bio stock is owned by insiders. Learn more on INMB's insider holdings. Which INmune Bio insiders have been buying company stock? The following insiders have purchased INMB shares in the last 24 months: David J Moss ($118,012.20), Raymond Joseph Tesi ($98,124.40), and Scott Juda ($85,000.00). How much insider buying is happening at INmune Bio? Insiders have purchased a total of 47,570 INMB shares in the last 24 months for a total of $301,136.60 bought. Which INmune Bio insiders have been selling company stock? The following insider sold INMB shares in the last 24 months: Timothy J Schroeder ($110,100.00). How much insider selling is happening at INmune Bio? Insiders have sold a total of 10,000 INmune Bio shares in the last 24 months for a total of $110,100.00 sold. INmune Bio Key ExecutivesDr. Raymond Joseph Tesi M.D. (Age 68)Co-Founder, President, CEO, Chief Medical Officer & Chairman Compensation: $500.5k1 recent tradesMr. David J. Moss M.B.A. (Age 54)CFO, Treasurer & Secretary Compensation: $394.9k2 recent tradesDr. Mark William Lowdell BSc (Age 61)FRCPath, MICR, MSc, Ph.D., Chief Scientific Officer & Chief Manufacturing Officer Compensation: $150.24kMr. Joshua S. Schoonover Esq.General Counsel More Insider Trading Tools from MarketBeat Related Companies Akebia Therapeutics Insider Buying Larimar Therapeutics Insider Buying Alector Insider Buying Amylyx Pharmaceuticals Insider Buying Alpha Teknova Insider Buying 4D Molecular Therapeutics Insider Buying Kodiak Sciences Insider Buying biote Insider Buying Jasper Therapeutics Insider Buying Sage Therapeutics Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:INMB) was last updated on 11/26/2024 by MarketBeat.com Staff From Our Partners❗[Investor Alert] Under-the-Radar TechWhile most investors are caught up in cryptocurrencies, AI stocks, or Jim Cramer's latest "hot pick…" One c...TuneGO | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThis Crisis Could Be Worse Than 2008Underneath the surface, cracks are forming. Cracks that threaten to shatter everything we know. America ...Behind the Markets | SponsoredIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...Chaikin Analytics | Sponsored140% Yields From Stocks Like Tesla? Here's How (Black Friday Special)140% Dividends from stocks like Tesla? Discover How for Just $9! For Black Friday, get the full details of ...Investors Alley | Sponsored9 hidden AI stocks set to thrive in Trump’s new eraAI ETFs are Booming, But These 9 AI Stocks are Better Plays By 2030, the AI industry is projected to be wor...StockEarnings | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding INmune Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share INmune Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
